COX-2 (also known as PTGS2), released by cancer-associated fibroblasts (CAFs) [33] and macrophage type 2 cells [34], is one of the key markers predicting worse cancer prognosis and stimulates cancer via multiple ways in the TME [35]. The gene discussed is PTGS2; the disease is cancer.